Watch Ticker

Briacell Therapeutics Corp. Common Shares

Go to Briacell Therapeutics Corp. Common Shares Website

$0.74

-0.04 (-4.60%)

Live

Previous Close

$0.7778

Day Range

$0 - $0

Previous Day Range

$0.755 - $0.7832

Market Cap

$13.3 million USD

Day Vol.

Previous Day Vol.

285839

Currency

USD

Primary Exchange

Nasdaq

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combin...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

William V. Williams, Md - BriaCell Announces Proposed Effective Date of Share Consolidation

BriaCell Therapeutics plans to consolidate its common shares at a 10:1 ratio to maintain Nasdaq listing requirements, effective August 25, 2025.

Related tickers: BCTX, BCTXW, BCTXZ.

Read Full Article

Briacell Therapeutics Corp. - BriaCell’s Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

BriaCell reported promising Phase 2 survival data for Bria-IMT immunotherapy in metastatic breast cancer, showing improved median overall survival compared to Trodelvy and single-agent chemotherapy across triple-negative and hormone receptor-positive breast cancer subtypes.

Related tickers: BCTX, BCTXW, BCTXZ.

Read Full Article

Trending Tickers

Please sign in to view